| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.5B | $11.9B | $12.0B | $12.2B | $13.7B | $14.1B | $9.1B | $6.8B |
| Cost of Revenue | $8.7B | $8.3B | $8.3B | $8.8B | $9.8B | $10.0B | $7.0B | $5.2B |
| Gross Profit | $3.8B | $3.6B | $3.7B | $3.4B | $3.9B | $4.1B | $2.1B | $1.6B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.0B | $-0.5B | $-0.8B | $-1.4B | $-0.1B | $0.4B | $-0.9B | $-0.5B |
| Net Income | $-0.3B | $-0.5B | $-0.7B | $-1.3B | $-0.1B | $0.2B | $-1.0B | $-0.5B |
| EPS (Basic) | $-2.44 | $-4.01 | $-6.47 | $-12.54 | $-1.26 | $1.93 | — | — |
| EPS (Diluted) | $-2.44 | $-4.01 | $-6.47 | $-12.54 | $-1.26 | $1.86 | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.4B | $3.5B | $3.5B | $3.6B | $4.6B | $4.6B | $3.0B | $1.9B |
| Current Assets | $2.0B | $1.9B | $1.9B | $1.9B | $3.0B | $3.0B | $1.4B | $1.3B |
| Cash & Equivalents | $1.5B | $1.3B | $1.3B | — | — | — | — | $0.8B |
| Total Liabilities | $6.2B | $6.2B | $6.2B | $6.1B | $6.2B | $5.8B | $3.9B | $2.2B |
| Current Liabilities | $2.1B | $2.4B | $2.2B | $2.1B | $2.2B | $2.2B | $1.6B | $1.1B |
| Stockholders' Equity | $-2.8B | $-2.8B | $-2.7B | $-2.5B | $-1.6B | $-1.2B | $-0.9B | $-0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.3B | $0.3B | $-0.7B | $0.4B | $1.4B | $-0.2B | $0.1B |
| Investing Cash Flow | $-0.2B | $-0.3B | $-0.2B | $0.0B | $-0.5B | $-0.2B | $-0.9B | $-0.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B | $0.2B | $0.3B | $0.2B |
| Financing Cash Flow | $-0.1B | $-0.1B | $0.1B | $0.0B | $-0.3B | $0.4B | $0.8B | $0.5B |